Goldman Sachs’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-200
Closed -$13K 6693
2017
Q3
$13K Hold
200
﹤0.01% 6506
2017
Q2
$11K Buy
+200
New +$10.4K ﹤0.01% 6643
2017
Q1
Sell
-500
Closed -$25K 7037
2016
Q4
$25K Sell
500
-200
-29% -$10.1K ﹤0.01% 6588
2016
Q3
$37K Sell
700
-2,400
-77% -$118K ﹤0.01% 6573
2016
Q2
$138K Hold
3,100
﹤0.01% 5955
2016
Q1
$127K Buy
3,100
+400
+15% +$14.7K ﹤0.01% 5936
2015
Q4
$99K Sell
2,700
-1,300
-33% -$47K ﹤0.01% 6179
2015
Q3
$131K Buy
4,000
+3,100
+344% +$104K ﹤0.01% 6305
2015
Q2
$33K Sell
900
-3,200
-78% -$116K ﹤0.01% 6985
2015
Q1
$144K Buy
4,100
+600
+17% +$21.2K ﹤0.01% 6237
2014
Q4
$133K Sell
3,500
-1,600
-31% -$58.5K ﹤0.01% 6432
2014
Q3
$181K Buy
5,100
+4,100
+410% +$152K ﹤0.01% 6236
2014
Q2
$39K Sell
1,000
-2,100
-68% -$78.5K ﹤0.01% 6797
2014
Q1
$113K Sell
3,100
-2,700
-47% -$98.5K ﹤0.01% 6358
2013
Q4
$201K Buy
5,800
+700
+14% +$22.5K ﹤0.01% 5961
2013
Q3
$142K Sell
5,100
-1,600
-24% -$42.7K ﹤0.01% 6049
2013
Q2
$180K Buy
+6,700
New +$185K ﹤0.01% 5653

Other funds holding XYL

Goldman Sachs's XYL Position: Q1 2026 in Review

Goldman Sachs increased its Xylem (XYL) stake by 3.5% in Q1 2026, buying an estimated $8.54M and bringing the position to 1,942,649 shares worth $232M. The position accounts for 0.03% of the portfolio, ranked #612.

Goldman Sachs first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $327M in Q4 2016. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Goldman Sachs held 1,942,649 shares of Xylem worth $232M as of Q1 2026.
  • Goldman Sachs bought 65,098 Xylem shares in Q1 2026, an estimated $8.54M.
  • Xylem made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #612 holding.
  • Goldman Sachs first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Xylem position peaked at $327M in Q4 2016.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.